There was no correlation of fibronectin expression with age, size of the residual disease, tumor grade, platinum sensitivity, TP53 accumulation, response to chemotherapy, type of tumor growth (solid versus papillary), mitotic activity, inflammatory infiltration, presence of necrosis, and calcifications in the tumor (Supplementary Table S1). This evidence concerns the gene FN1 and neoplasm.